90 related articles for article (PubMed ID: 25859994)
1. Low rates of recurrence after successful treatment of multidrug-resistant tuberculosis in Tomsk, Russia.
Gelmanova IY; Ahmad Khan F; Becerra MC; Zemlyanaya NA; Unakova IA; Andreev YG; Berezina VI; Pavlova VE; Shin S; Yedilbayev AB; Krasnov VA; Keshavjee S
Int J Tuberc Lung Dis; 2015 Apr; 19(4):399-405. PubMed ID: 25859994
[TBL] [Abstract][Full Text] [Related]
2. Aggressive Regimens Reduce Risk of Recurrence After Successful Treatment of MDR-TB.
Ahmad Khan F; Gelmanova IY; Franke MF; Atwood S; Zemlyanaya NA; Unakova IA; Andreev YG; Berezina VI; Pavlova VE; Shin SS; Yedilbayev AB; Becerra MC; Keshavjee S
Clin Infect Dis; 2016 Jul; 63(2):214-20. PubMed ID: 27161772
[TBL] [Abstract][Full Text] [Related]
3. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].
Saito W; Nagayama N; Miyamoto M; Hara H; Suzuki J; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Yotsumoto H
Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568
[TBL] [Abstract][Full Text] [Related]
4. Treatment and follow-up of HIV-negative multidrug-resistant tuberculosis patients in an infectious diseases reference hospital, Buenos Aires, Argentina.
Palmero DJ; Ambroggi M; Brea A; De Lucas M; Fulgenzi A; Martínez D; Mosca C; Musella R; Natiello M; Gonzalez C; Abbate E
Int J Tuberc Lung Dis; 2004 Jun; 8(6):778-84. PubMed ID: 15182150
[TBL] [Abstract][Full Text] [Related]
5. Treatment outcomes in an integrated civilian and prison MDR-TB treatment program in Russia.
Shin SS; Pasechnikov AD; Gelmanova IY; Peremitin GG; Strelis AK; Mishustin S; Barnashov A; Karpeichik Y; Andreev YG; Golubchikova VT; Tonkel TP; Yanova GV; Nikiforov M; Yedilbayev A; Mukherjee JS; Furin JJ; Barry DJ; Farmer PE; Rich ML; Keshavjee S
Int J Tuberc Lung Dis; 2006 Apr; 10(4):402-8. PubMed ID: 16602404
[TBL] [Abstract][Full Text] [Related]
6. Highly successful treatment outcome of multidrug-resistant tuberculosis in the Netherlands, 2000-2009.
van Altena R; de Vries G; Haar CH; de Lange WC; Magis-Escurra C; van den Hof S; van Soolingen D; Boeree MJ; van der Werf TS
Int J Tuberc Lung Dis; 2015 Apr; 19(4):406-12. PubMed ID: 25859995
[TBL] [Abstract][Full Text] [Related]
7. Predictors of recurrence of multidrug-resistant and extensively drug-resistant tuberculosis.
Blöndal K; Viiklepp P; Guðmundsson LJ; Altraja A
Int J Tuberc Lung Dis; 2012 Sep; 16(9):1228-33. PubMed ID: 22748131
[TBL] [Abstract][Full Text] [Related]
8. Drug-resistant tuberculosis in Israel: risk factors and treatment outcomes.
Mor Z; Goldblatt D; Kaidar-Shwartz H; Cedar N; Rorman E; Chemtob D
Int J Tuberc Lung Dis; 2014 Oct; 18(10):1195-201. PubMed ID: 25216833
[TBL] [Abstract][Full Text] [Related]
9. Recurrence after Successful Treatment of Multidrug-Resistant Tuberculosis in Taiwan.
Chen MY; Lo YC; Chen WC; Wang KF; Chan PC
PLoS One; 2017; 12(1):e0170980. PubMed ID: 28125692
[TBL] [Abstract][Full Text] [Related]
10. Recurrence after successful treatment among patients with multidrug-resistant tuberculosis.
Lee J; Lim HJ; Cho YJ; Park YS; Lee SM; Yang SC; Yoo CG; Kim YW; Han SK; Yim JJ
Int J Tuberc Lung Dis; 2011 Oct; 15(10):1331-3. PubMed ID: 22283890
[TBL] [Abstract][Full Text] [Related]
11. Predictors and mortality associated with treatment default in pulmonary tuberculosis.
Kliiman K; Altraja A
Int J Tuberc Lung Dis; 2010 Apr; 14(4):454-63. PubMed ID: 20202304
[TBL] [Abstract][Full Text] [Related]
12. The treatment results of patients with multidrug resistant tuberculosis and factors affecting treatment outcome.
Karagöz T; Yazicioğlu Moçin O; Pazarli P; Senol T; Yetiş Duman D; Duman G; Saltürk C; Unal O; Halezeroğlu S
Tuberk Toraks; 2009; 57(4):383-92. PubMed ID: 20037853
[TBL] [Abstract][Full Text] [Related]
13. Frequency of recurrence among MDR-tB cases 'successfully' treated with standardised short-course chemotherapy.
Migliori GB; Espinal M; Danilova ID; Punga VV; Grzemska M; Raviglione MC
Int J Tuberc Lung Dis; 2002 Oct; 6(10):858-64. PubMed ID: 12365571
[TBL] [Abstract][Full Text] [Related]
14. Treatment outcome and follow-up of multidrug-resistant tuberculosis patients, West Coast/Winelands, South Africa, 1992-2002.
Shean KP; Willcox PA; Siwendu SN; Laserson KF; Gross L; Kammerer S; Wells CD; Holtz TH
Int J Tuberc Lung Dis; 2008 Oct; 12(10):1182-9. PubMed ID: 18812049
[TBL] [Abstract][Full Text] [Related]
15. API TB Consensus Guidelines 2006: Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations.
API Consensus Expert Committee
J Assoc Physicians India; 2006 Mar; 54():219-34. PubMed ID: 16800350
[TBL] [Abstract][Full Text] [Related]
16. Countrywide management of pulmonary tuberculosis reverses increasing incidence.
Blöndal K; Viiklepp P; Blöndal P; Altraja A
Int J Tuberc Lung Dis; 2011 Jul; 15(7):892-8. PubMed ID: 21682961
[TBL] [Abstract][Full Text] [Related]
17. Body mass index predictive of sputum culture conversion among MDR-TB patients in Indonesia.
Putri FA; Burhan E; Nawas A; Soepandi PZ; Sutoyo DK; Agustin H; Isbaniah F; Dowdy DW
Int J Tuberc Lung Dis; 2014 May; 18(5):564-70. PubMed ID: 24903794
[TBL] [Abstract][Full Text] [Related]
18. [Drug resistant tuberculosis].
Zwolska Z; Augustynowicz-Kopeć E
Pol Merkur Lekarski; 2011 May; 30(179):362-6. PubMed ID: 21675144
[TBL] [Abstract][Full Text] [Related]
19. Cost and cost-effectiveness of multidrug-resistant tuberculosis treatment in Estonia and Russia.
Floyd K; Hutubessy R; Kliiman K; Centis R; Khurieva N; Jakobowiak W; Danilovits M; Peremitin G; Keshavjee S; Migliori GB
Eur Respir J; 2012 Jul; 40(1):133-42. PubMed ID: 22362862
[TBL] [Abstract][Full Text] [Related]
20. Treatment outcome of relapse and defaulter pulmonary tuberculosis patients.
Sevim T; Ataç G; Güngör G; Törün I; Aksoy E; Gemci ; Tahaoglu K
Int J Tuberc Lung Dis; 2002 Apr; 6(4):320-5. PubMed ID: 11936741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]